News & Media

Overview

To Onyx's knowledge, all press releases, scientific papers, and abstracts and the information contained within them were timely and accurate when issued. The continued accuracy of this material beyond the date of issuance and posting on the website is not assured. Onyx has no intention of updating this information, and specifically disclaims any duty to do so. These documents may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties.

Please see Terms of Use for this website.

Media Contacts

Lori Melançon Danielle Bertrand
650.266.2394 650.266.2114
 
Onyx Pharmaceuticals, Inc.
249 E. Grand  Avenue
South San Francisco, CA 94080
 

Information Request